These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 9388150)
21. Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, Italy. Maio V; Gagne JJ J Clin Pharm Ther; 2010 Feb; 35(1):55-61. PubMed ID: 20175812 [TBL] [Abstract][Full Text] [Related]
22. [Rational prescribing and cost reduction in the treatment of arterial hypertension: a simulation exercise]. Bonet A; Gosalbes V; Fito M; Navarro J Gac Sanit; 2001; 15(4):327-35. PubMed ID: 11578562 [TBL] [Abstract][Full Text] [Related]
23. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study. Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595 [TBL] [Abstract][Full Text] [Related]
24. Improving cost-effectiveness of hypertension management at a community health centre. Edwards PR; Lunt DW; Fehrsen GS; Lombard CJ; Steyn K S Afr Med J; 1998 May; 88(5):549-54. PubMed ID: 9638122 [TBL] [Abstract][Full Text] [Related]
25. Antihypertensive Drug Therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year. Alderman MH; Madhavan S; Cohen H Am J Hypertens; 1996 May; 9(5):413-8. PubMed ID: 8735170 [TBL] [Abstract][Full Text] [Related]
26. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
27. The cost effectiveness of ACE inhibitors as first-line antihypertensive therapy. Nordmann AJ; Krahn M; Logan AG; Naglie G; Detsky AS Pharmacoeconomics; 2003; 21(8):573-85. PubMed ID: 12751915 [TBL] [Abstract][Full Text] [Related]
28. The need for evidence in hypertension management: historical perspective. Moawad MA Ann Saudi Med; 2005; 25(5):367-74. PubMed ID: 16270757 [TBL] [Abstract][Full Text] [Related]
29. The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis. Fretheim A; Aaserud M; Oxman AD BMC Health Serv Res; 2003 Sep; 3(1):18. PubMed ID: 12959644 [TBL] [Abstract][Full Text] [Related]
30. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. Campbell NR; McAlister FA; Brant R; Levine M; Drouin D; Feldman R; Herman R; Zarnke K; J Hypertens; 2003 Aug; 21(8):1591-7. PubMed ID: 12872055 [TBL] [Abstract][Full Text] [Related]
31. An economic evaluation of the JNC hypertension guidelines using data from a randomized controlled trial. Joint National Committee. Ramsey SD; Neil N; Sullivan SD; Perfetto E J Am Board Fam Pract; 1999; 12(2):105-14. PubMed ID: 10220232 [TBL] [Abstract][Full Text] [Related]
32. Current recommendations for the treatment of hypertension: are they still valid? Moser M J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197 [TBL] [Abstract][Full Text] [Related]
33. Patterns of utilization of antihypertensive drug combinations in Bahrain: do they conform with international guidelines? Jassim Al Khaja KA; Sequeira RP; Mathur VS Int J Clin Pharmacol Ther; 2000 Dec; 38(12):568-80. PubMed ID: 11125870 [TBL] [Abstract][Full Text] [Related]
34. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study. Psaty BM; Savage PJ; Tell GS; Polak JF; Hirsch CH; Gardin JM; McDonald RH JAMA; 1993 Oct; 270(15):1837-41. PubMed ID: 8105112 [TBL] [Abstract][Full Text] [Related]
35. Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians. Ubel PA; Jepson C; Asch DA J Gen Intern Med; 2003 Dec; 18(12):977-83. PubMed ID: 14687255 [TBL] [Abstract][Full Text] [Related]
36. Cochrane in context: pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306 [TBL] [Abstract][Full Text] [Related]
37. The use of antihypertensive therapy in Spain (1986-1994). Jabary NS; Herrero AM; Gonzalez JA Am J Hypertens; 2000 Jun; 13(6 Pt 1):607-10. PubMed ID: 10912742 [TBL] [Abstract][Full Text] [Related]
38. Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain. Al Khaja KA; Sequeira RP; Mathur VS Ann Pharmacother; 2001 Nov; 35(11):1350-9. PubMed ID: 11724081 [TBL] [Abstract][Full Text] [Related]
39. PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998. Nelson MR; McNeil JJ; Peeters A; Reid CM; Krum H Med J Aust; 2001 Jun; 174(11):565-8. PubMed ID: 11453328 [TBL] [Abstract][Full Text] [Related]
40. Antihypertensive drug prescribing in Grampian. Ross S; Macleod MJ Br J Clin Pharmacol; 2005 Sep; 60(3):300-5. PubMed ID: 16120069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]